Bye-bye, HPV: New vaccine clears lesions in clinical trial

A new vaccine is looking promising as a nonsurgical treatment for existing precancerous and cancerous cervical lesions, according to scientists at Johns Hopkins University in the US.A genetically engineered vaccine eradicated high-grade precancerous cervical lesions in almost half of women participating in a clinical trial at Johns Hopkins University in the US. Not to be confused with preventative vaccines such as Gardasil, the new treatment could provide a nonsurgical solution for existing precancerous lesions caused by the human papillomavirus (HPV) that's typically spread through sexual contact. Women aged 40 or younger are the most likely to develop high-grade cervical lesions, and existing solutions are invasive and include surgery, freezing or laser treatment, says Dr. Trimble.



Sexual Health News Headlines – Yahoo! News